Covid-19 Messaging to Underserved Communities - 2nd Experiment

NCT04502056 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20460

Last updated 2021-07-27

Study results available
· View outcomes & findings →

Summary

The aim of the study is to build off results from our first experiment (NCT04371419) , and test whether messages that acknowledge racial injustice on behalf of institutions affect the retention of knowledge and movement of beliefs and behavior with respect to Covid-19. The investigators will also test the effect of concordance of providers and whether highlighting the unequal burden of the disease has additional effects on knowledge, beliefs and behavior regarding covid-19. The sample will include African American and white adult Americans and oversample those with less than a college degree.

Conditions

  • Covid19

Interventions

BEHAVIORAL

Acknowledgement Racial Injustice AMA

Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants will receive a AMA statement on racial injustice.

BEHAVIORAL

African American Sender Acknowledgement

Investigators will also vary the messenger of the acknowledgement sender. In this arm participants receive a African American sender in acknowledgment of AMA

BEHAVIORAL

African American Sender in Informational Videos.

Investigators will vary the sender of the informational covid-19 videos. In this arm, participants receive a African American sender in informational videos.

BEHAVIORAL

Racial Inequality Highlighted

Investigators will include information on race-specific covid-19 cases and deaths in one variation in the messaging. In this arm, participants receive disproportionate race-specific Covid-19 facts

BEHAVIORAL

AMA Acknowledgement Drug Pricing

Investigators will examine whether acknowledgements of racial inequality are helpful towards improving knowledge retention and behaviors associated with the intervention among participants. In this arm, participants receive AMA information on drug pricing

BEHAVIORAL

White Sender in Acknowledgement

Investigators will also vary the messenger of the acknowledgement sender. In this arm, participants receive a white sender in the acknowledgement

BEHAVIORAL

White Sender in Informational Videos

Investigators will vary the messenger of the informational covid-19 videos. In this arm, participants receive white sender in the informational video

BEHAVIORAL

No Racial Inequality Highlighting

In this arm, the disproportionate burden of Covid-19 on communities of color will not be highlighted

BEHAVIORAL

Placebo videos

Videos not related to covid-19 will be shown

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER
  • Stanford University

    collaborator OTHER
  • Yale University

    collaborator OTHER
  • Harvard University

    collaborator OTHER
  • National Bureau of Economic Research, Inc.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-07
Primary Completion
2020-09-06
Completion
2020-09-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04502056 on ClinicalTrials.gov